COVID-19 has proved to be a serious, and consequential disease that has affected millions
of people globally. Previously, the adverse effects of proton pump inhibitors (PPI) have been …

Purpose Several observational studies have presented conflicting results on the association
between the use of proton pump inhibitors (PPIs) or histamine H2 receptor antagonist …

Background Cardiovascular disease (CVD), one of the most common comorbidities of
coronavirus disease 2019 (COVID-19), has been suspected to be associated with adverse …

Currently, there is great interest in identifying safe and effective existing drug therapies for
the prevention of coronavirus-2019(COVID-19). Recently, there is a surge of observational …

Introduction Severe acute respiratory syndrome coronavirus 2 is a viral respiratory infection
that can cause systemic disorders and lead to death, particularly in older people. Proton …

Background We aimed to understand the association of gastrointestinal (GI) symptoms at
initial presentation with clinical outcomes during COVID-19 hospitalization. Methods This …

This Perspective examines a recent surge of information regarding the potential benefits of
acid-suppression drugs in the context of COVID-19, with a particular eye on the great …

Background This study aimed to identify the effect of histamine-2 receptor antagonist (H2RA)
and proton pump inhibitor (PPI) use on the positivity rate and clinical outcomes of …

Анализ публикаций, посвященных влиянию ингибиторов протонного насоса (ИПН) на
частоту возникновения и течение инфекции COVID-19 свидетельствует о том, что …

COVID-19 has spurred much interest in the therapeutic potential of repurposed drugs. A
family of acid-reducing drugs, known as histamine H2 receptor antagonists (H2RA) …